# Tigo Energy, Inc.: financial statements, quarterly

TYGO · Nasdaq · CIK 1855447 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tygo.md) · [Financials](/companies/tygo/financials.md) · [Filings](/companies/tygo/filings.md) · [Insiders](/companies/tygo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tygo/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [17.1](/filings/0000950170-24-122269.md) | [9.2 d](/filings/0000950170-25-042645.md) | [0.0](/filings/0000950170-25-064433.md) | [0.0](/filings/0000950170-25-103189.md) | [0.0](/filings/0001193125-25-264656.md) | [54.0 d](/filings/0001193125-26-115952.md) | [0.0](/filings/0001855447-26-000003.md) | [0.0](/filings/0001855447-26-000007.md) | [0.0](/filings/0001193125-25-264656.md) | [103 d](/filings/0001193125-26-115952.md) | [0.0](/filings/0001855447-26-000003.md) | [0.0](/filings/0001855447-26-000007.md) |
| Cost of revenue | $bn | [0.0](/filings/0000950170-24-122269.md) | [0.0 d](/filings/0000950170-25-042645.md) | [0.0](/filings/0000950170-25-064433.md) | [0.0](/filings/0000950170-25-103189.md) | [0.0](/filings/0001193125-25-264656.md) | [0.0 d](/filings/0001193125-26-115952.md) | [0.0](/filings/0001855447-26-000003.md) | [0.0](/filings/0001855447-26-000007.md) | [0.0](/filings/0001193125-25-264656.md) | [0.0 d](/filings/0001193125-26-115952.md) | [0.0](/filings/0001855447-26-000003.md) | [0.0](/filings/0001855447-26-000007.md) |
| Gross profit | $bn | [0.0](/filings/0000950170-24-122269.md) | [0.0 d](/filings/0000950170-25-042645.md) | [0.0](/filings/0000950170-25-064433.md) | [0.0](/filings/0000950170-25-103189.md) | [0.0](/filings/0001193125-25-264656.md) | [(0.0) d](/filings/0001193125-26-115952.md) | [0.0](/filings/0001855447-26-000003.md) | [0.0](/filings/0001855447-26-000007.md) | [0.0](/filings/0001193125-25-264656.md) | [0.0 d](/filings/0001193125-26-115952.md) | [0.0](/filings/0001855447-26-000003.md) | [0.0](/filings/0001855447-26-000007.md) |
| Research and development | $bn | [0.0](/filings/0000950170-24-122269.md) | [0.0 d](/filings/0000950170-25-042645.md) | [0.0](/filings/0000950170-25-064433.md) | [0.0](/filings/0000950170-25-103189.md) | [0.0](/filings/0001193125-25-264656.md) | [0.0 d](/filings/0001193125-26-115952.md) | [0.0](/filings/0001855447-26-000003.md) | [0.0](/filings/0001855447-26-000007.md) | [0.0](/filings/0001193125-25-264656.md) | [0.0 d](/filings/0001193125-26-115952.md) | [0.0](/filings/0001855447-26-000003.md) | [0.0](/filings/0001855447-26-000007.md) |
| Operating income | $bn | [(0.0)](/filings/0000950170-24-122269.md) | [(0.0) d](/filings/0000950170-25-042645.md) | [(0.0)](/filings/0000950170-25-064433.md) | [(0.0)](/filings/0000950170-25-103189.md) | [(0.0)](/filings/0001193125-25-264656.md) | [(0.0) d](/filings/0001193125-26-115952.md) | [(0.0)](/filings/0001855447-26-000003.md) | [(0.0)](/filings/0001855447-26-000007.md) | [0.0](/filings/0001193125-25-264656.md) | [0.0 d](/filings/0001193125-26-115952.md) | [(0.0)](/filings/0001855447-26-000003.md) | [(0.0)](/filings/0001855447-26-000007.md) |
| Interest expense | $bn | [(0.0)](/filings/0000950170-23-060233.md) | [0.0 d](/filings/0000950170-24-034765.md) | [0.0](/filings/0000950170-24-059479.md) | [0.0](/filings/0000950170-24-091765.md) | [0.0](/filings/0001193125-25-264656.md) | [0.0 d](/filings/0001193125-26-115952.md) | [0.0](/filings/0001855447-26-000003.md) | [0.0](/filings/0001855447-26-000007.md) | [0.0](/filings/0001193125-25-264656.md) | [0.0 d](/filings/0001193125-26-115952.md) | [0.0](/filings/0001855447-26-000003.md) | [0.0](/filings/0001855447-26-000007.md) |
| Income tax | $bn | [0.0](/filings/0000950170-24-122269.md) | [0.0 d](/filings/0000950170-25-042645.md) | [0.0](/filings/0000950170-25-064433.md) | [0.0](/filings/0000950170-25-103189.md) | [0.0](/filings/0000950170-24-122269.md) | [0.0 d](/filings/0001193125-26-115952.md) | [0.0](/filings/0001855447-26-000003.md) | [0.0](/filings/0001855447-26-000007.md) | [0.0](/filings/0001193125-25-264656.md) | [(0.0) d](/filings/0001193125-26-115952.md) | [(0.0)](/filings/0001855447-26-000003.md) | [(0.0)](/filings/0001855447-26-000007.md) |
| Net income | $bn | [0.0](/filings/0000950170-24-122269.md) | [(0.0) d](/filings/0000950170-25-042645.md) | [(0.0)](/filings/0001193125-25-264656.md) | [(0.0)](/filings/0001193125-25-264656.md) | [(0.0)](/filings/0001193125-25-264656.md) | [(0.0) d](/filings/0001193125-26-115952.md) | [(0.0)](/filings/0001855447-26-000007.md) | [(0.0)](/filings/0001855447-26-000007.md) | [(0.0)](/filings/0001193125-25-264656.md) | [0.0 d](/filings/0001193125-26-115952.md) | [(0.0)](/filings/0001855447-26-000007.md) | [0.0](/filings/0001855447-26-000007.md) |
| Diluted EPS | $ per share | [(0.27)](/filings/0000950170-24-122269.md) | not reported | [(0.19)](/filings/0000950170-25-064433.md) | [(0.19)](/filings/0000950170-25-103189.md) | [(0.22)](/filings/0001193125-25-264656.md) | not reported | [(0.11)](/filings/0001855447-26-000003.md) | [(0.07)](/filings/0001855447-26-000007.md) | [(0.03)](/filings/0001193125-25-264656.md) | not reported | [(0.02)](/filings/0001855447-26-000003.md) | [0.03](/filings/0001855447-26-000007.md) |
| Basic EPS | $ per share | [0.50](/filings/0000950170-24-122269.md) | not reported | [(0.19)](/filings/0000950170-25-064433.md) | [(0.19)](/filings/0000950170-25-103189.md) | [(0.22)](/filings/0001193125-25-264656.md) | not reported | [(0.11)](/filings/0001855447-26-000003.md) | [(0.07)](/filings/0001855447-26-000007.md) | [(0.03)](/filings/0001193125-25-264656.md) | not reported | [(0.02)](/filings/0001855447-26-000003.md) | [0.03](/filings/0001855447-26-000007.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2.2](/filings/0000950170-23-060233.md) | [4.4](/filings/0000950170-25-042645.md) | [9.0](/filings/0000950170-24-059479.md) | [14.9](/filings/0000950170-24-091765.md) | [9.5](/filings/0000950170-24-122269.md) | [11.7](/filings/0001193125-26-115952.md) | [8.5](/filings/0000950170-25-064433.md) | [10.2](/filings/0000950170-25-103189.md) | [24.5](/filings/0001193125-25-264656.md) | [7.7](/filings/0001855447-26-000007.md) | [11.6](/filings/0001855447-26-000003.md) | [16.9](/filings/0001855447-26-000007.md) |
| Current assets | $m | [117](/filings/0000950170-23-060233.md) | [105](/filings/0000950170-25-042645.md) | [88.4](/filings/0000950170-24-059479.md) | [83.1](/filings/0000950170-24-091765.md) | [78.7](/filings/0000950170-24-122269.md) | [53.4](/filings/0001193125-26-115952.md) | [51.8](/filings/0000950170-25-064433.md) | [60.4](/filings/0000950170-25-103189.md) | [87.8](/filings/0001193125-25-264656.md) | [58.0](/filings/0001855447-26-000007.md) | [55.1](/filings/0001855447-26-000003.md) | [54.6](/filings/0001855447-26-000007.md) |
| Total assets | $m | [143](/filings/0000950170-23-060233.md) | [128](/filings/0000950170-25-042645.md) | [109](/filings/0000950170-24-059479.md) | [103](/filings/0000950170-24-091765.md) | [98.6](/filings/0000950170-24-122269.md) | [72.9](/filings/0001193125-26-115952.md) | [70.6](/filings/0000950170-25-064433.md) | [80.6](/filings/0000950170-25-103189.md) | [108](/filings/0001193125-25-264656.md) | [78.0](/filings/0001855447-26-000007.md) | [74.9](/filings/0001855447-26-000003.md) | [77.9](/filings/0001855447-26-000007.md) |
| Current liabilities | $m | [30.1](/filings/0000950170-23-060233.md) | [26.4](/filings/0000950170-25-042645.md) | [14.2](/filings/0000950170-24-059479.md) | [15.5](/filings/0000950170-24-091765.md) | [19.9](/filings/0000950170-24-122269.md) | [17.1](/filings/0001193125-26-115952.md) | [58.3](/filings/0000950170-25-064433.md) | [68.0](/filings/0000950170-25-103189.md) | [84.9](/filings/0001193125-25-264656.md) | [38.8](/filings/0001855447-26-000007.md) | [22.4](/filings/0001855447-26-000003.md) | [17.9](/filings/0001855447-26-000007.md) |
| Total liabilities | $m | [67.3](/filings/0000950170-23-060233.md) | [65.0](/filings/0000950170-25-042645.md) | [54.8](/filings/0000950170-24-059479.md) | [58.6](/filings/0000950170-24-091765.md) | [65.1](/filings/0000950170-24-122269.md) | [64.5](/filings/0001193125-26-115952.md) | [66.9](/filings/0000950170-25-064433.md) | [79.0](/filings/0000950170-25-103189.md) | [95.8](/filings/0001193125-25-264656.md) | [50.4](/filings/0001855447-26-000007.md) | [34.0](/filings/0001855447-26-000003.md) | [33.2](/filings/0001855447-26-000007.md) |
| Long-term debt | $m | [29.3](/filings/0000950170-23-060233.md) | [31.6](/filings/0000950170-25-042645.md) | [33.8](/filings/0000950170-24-059479.md) | [36.0](/filings/0000950170-24-091765.md) | [38.3](/filings/0000950170-24-122269.md) | [40.5](/filings/0001193125-26-115952.md) | [0.0](/filings/0000950170-25-064433.md) | [50.0](/filings/0000950170-25-103189.md) | [50.0](/filings/0001193125-25-264656.md) | [0.0](/filings/0001855447-26-000007.md) | [0.0](/filings/0001855447-26-000003.md) | [4.1](/filings/0001855447-26-000007.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | [42.7](/filings/0000950170-25-064433.md) | [45.0](/filings/0000950170-25-103189.md) | [47.2](/filings/0001193125-25-264656.md) | not reported | not reported | not reported |
| Shareholders' equity | $m | [75.8](/filings/0000950170-24-122269.md) | [62.8](/filings/0001193125-26-115952.md) | [54.3](/filings/0001193125-25-264656.md) | [44.7](/filings/0001193125-25-264656.md) | [33.5](/filings/0001193125-25-264656.md) | [8.4](/filings/0001855447-26-000007.md) | [3.8](/filings/0001855447-26-000007.md) | [1.7](/filings/0001855447-26-000007.md) | [12.1](/filings/0001193125-25-264656.md) | [27.6](/filings/0001855447-26-000007.md) | [40.8](/filings/0001855447-26-000007.md) | [44.6](/filings/0001855447-26-000007.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(24.4) d](/filings/0000950170-24-122269.md) | [(7.8) d](/filings/0000950170-25-042645.md) | [(11.3)](/filings/0000950170-25-064433.md) | [(1.6) d](/filings/0000950170-25-103189.md) | [(0.5) d](/filings/0001193125-25-264656.md) | [1.1 d](/filings/0001193125-26-115952.md) | [(0.5)](/filings/0001855447-26-000003.md) | [7.8 d](/filings/0001855447-26-000007.md) | [1.4 d](/filings/0001193125-25-264656.md) | [1.6 d](/filings/0001193125-26-115952.md) | [(9.3)](/filings/0001855447-26-000003.md) | [(1.0) d](/filings/0001855447-26-000007.md) |
| Capital expenditure | $m | [0.3 d](/filings/0000950170-24-122269.md) | [0.3 d](/filings/0000950170-25-042645.md) | [0.4](/filings/0000950170-25-064433.md) | [0.1 d](/filings/0000950170-25-103189.md) | [0.3 d](/filings/0001193125-25-264656.md) | [0.5 d](/filings/0001193125-26-115952.md) | not reported | not reported | [(0.0) d](/filings/0001193125-25-264656.md) | [0.4 d](/filings/0001193125-26-115952.md) | [0.2](/filings/0001855447-26-000003.md) | [0.3 d](/filings/0001855447-26-000007.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [4.9](/filings/0000950170-23-060233.md) | [11.0](/filings/0000950170-24-059479.md) | [27.8](/filings/0000950170-24-091765.md) | [68.4](/filings/0000950170-24-122269.md) | [59.4](/filings/0000950170-25-064433.md) | [60.4](/filings/0000950170-25-103189.md) | [60.6](/filings/0001193125-25-264656.md) | [61.7](/filings/0001855447-26-000003.md) | [62.3](/filings/0001855447-26-000007.md) | [65.7](/filings/0001193125-25-264656.md) | [72.6](/filings/0001855447-26-000003.md) | [80.6](/filings/0001855447-26-000007.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 76,773,711 at 2026-07-30, from the cover of the [10-Q filed 2026-08-04](/filings/0001855447-26-000007.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.